Posts Tagged ‘Switzerland’
FONGIT Innovation Fund
Send your application before 13 May 2026 for the FONGIT Innovation Fund (FIF) FONGIT, Fondation Genevoise pour l’Innovation Technologique, is the first innovation incubator in Switzerland, specialising in technological innovation in Geneva. The organisation currently supports more than 100 startups and projects in the fields of ICT, Engineering, and Life Sciences. It helps innovative projects…
Read MoreBioAlps and the Swiss Health Valley
Listen to Magali Bischof, BioAlps Secretary General, on Beyond Biotech podcast speaking about the Swiss Health Valley and the role of BioAlps association. Here is the transcription of the interview. ▶️ Listen to the podcast on Labiotech.eu | From 00:31:50 to 47:30 Could you tell us about BioAlps – when it was formed,…
Read MoreBIONOMOUS closes a USD 2.7 million Series A
The Swiss-based startup builds devices to automate processes in Life Science research and prepares a product rollout and expansion. The round was led by Nivalis Group, a Swiss Holding based in Villaz-St-Pierre, with participation from Cybernetix Ventures, a leading robotics-focused US venture capital firm based in the Boston, and Capital Risque Fribourg, an early-stage…
Read MoreA CHF 1.5M seed-funding round for MPC Therapeutics to improve CAR-T cancer therapies
MPC Therapeutics (MPC Tx), is a Swiss biotechnology company based in Geneva, focusing on metabolism and cellular rejuvenation. The company announced the closing of its CHF 1.5 million seed-funding round. Funds will serve to advance MPC Tx’s proprietary small molecule towards clinical trials and open new therapeutic applications. The funding round was led by…
Read MoremimiX biotherapeutics launches a funding round to accelerate clinical translation of FastSkin®
mimiX biotherapeutics launches a funding round to accelerate clinical translation of FastSkin® MIMIX BIOTHERAPEUTICS LTD, a Swiss medical technology company focused on life sciences, with a next-generation 3D bioprinting platform using proprietary Sound Induced Morphogenesis (SIM), announces that the company is accelerating the clinical translation of FastSkin®. FastSkin® is an advanced dermal substitute for acute…
Read MoreAMF Medical SA bought for CHF 200 million by Tandem Diabetes Care
Tandem Diabetes Care, a global US-Based insulin delivery and diabetes technology company, announced an agreement to acquire AMF Medical SA, the privately held Swiss developer of the Sigi™ Patch Pump based at EPFL Innovation Park in Lausanne. The full agreement could reach CHF 200 million but is subject to future technical developments and FDA approval…
Read MoreMRM wins the Debiopharm – La Solution – Inartis Challenge
The 7th Debiopharm-La-Solution.ch-Inartis Challenge for the Quality of Life of Patient has rewarded with a prize of CHF 25’000 the MRM project. It was selected among 5 finalists who, last July, received 5000 Swiss francs each to develop a prototype. The winner was selected by a jury of healthcare and media professionals from among…
Read MoreAlliance, your partner for your Innosuisse application
You have an innovative project and are thinking of submitting an Innosuisse application? With its team of specialized advisors, Alliance is your ally! Between 2020 and 2021, the EPFL based association has raised over CHF 57 million for Swiss SMEs. What is Alliance and how was the structure created? Alliance is the technological innovation…
Read MoreSwitzerland sets to accept medical devices with FDA approval
The Federal Council is to adapt national laws so that, in addition to medical devices with an EU certificate / CE mark, medical devices with U.S. Food & Drug Administration (FDA) approval will now also be recognised in Switzerland. Although not an EU member state or even part of the European Economic Area, Switzerland…
Read MoreEUR 3.7 million for ONWARD and its partners from the European Innovation Council (EIC)
The European Innovation Council Grant has been awarded to ONWARD and its research partners, including EPFL, IICT-BAS, CEA-Leti-Clinatec, and CEAList. The company also received the First Place Winner of the 2022 Brain-Computer Interface (BCI) Award. ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in…
Read More